To uncover the correlation between immunotherapy and CD44 in glioma, we extracted bulk RNA-seq data of patients with recurrent GBM receiving adjuvant, postsurgical PD-1 blockade therapy from this study. The gene discussed is CD44; the disease is glioblastoma.